Mayank Bansal, CFA
Mayank Bansal is a CFA Charterholder and heads the Equity Research team at Kapitales Research, with over 5 years of experience analysing global equity markets. He leads fundamental, data-driven research combining rigorous financial analysis with macro trends.
3 ASX Stocks in Focus as Shares Post Strong Gains Amid Key Company Updates
Highlights
ASX Market Movers in FocusASX Market Movers in Focus
Several ASX-listed companies attracted investor attention following corporate announcements released between 29 September and 1 October 2026. Silex Systems Limited (ASX: SLX), IMDEX Limited (ASX: IMD) and Cochlear Limited (ASX: COH) were among the stocks recording notable gains, with their latest company disclosures providing fresh developments for investors. Based on the market data provided, Silex Systems rose 5.035% to AU$4.380, while IMDEX gained 4.407% to AU$3.435. Cochlear advanced 3.820% to AU$130.180.
Silex Systems Gains as Vanguard Becomes Substantial Holder
On 1 October 2026, Silex Systems disclosed a Form 603 notice stating that Vanguard Group had attained substantial holder status in the company on 28 September 2026. Vanguard reported a relevant interest in 13,940,307 ordinary shares, representing voting power of 5.012%. The filing noted that Vanguard oversees a range of mutual funds and investment accounts, giving it the authority to dispose of the shares. The accompanying transaction records show a series of purchases and sales involving Vanguard entities during the period leading up to the substantial holding notification. Silex Systems shares were quoted at AU$4.380, up 5.035% based on the supplied market data.
IMDEX Issues 1.83 Million Performance Rights
On 30 September 2026, IMDEX announced the issue of 1,832,960 performance rights under its employee incentive arrangements. On 1 October 2026, Silex Systems disclosed in a Form 603 notice that Vanguard Group had become a substantial holder of the company on 28 September 2026. The company disclosed that the performance rights can convert into ordinary shares once the relevant vesting requirement is satisfied, including continuity of employment through 30 June 2027, subject to the Employee Rights Plan approved by shareholders in October 2024. IMDEX shares gained 4.407% to AU$3.435 according to the supplied market data.
Cochlear Faces Class Action Proceedings
Cochlear announced on 29 September 2026 that it had received a class action claim filed in the Supreme Court of Victoria. The legal action involves investors who acquired Cochlear shares between 15 August 2025 and 21 April 2026, with the claims relating to the company’s underlying net profit guidance for FY26. Cochlear has rejected the claims and confirmed that it intends to defend the proceedings. Despite the legal development, the company's shares rose 3.820% to AU$130.180 based on the supplied market data.
Market Outlook
The three announcements highlight different developments across technology, mining services and healthcare. While institutional ownership, employee incentive arrangements and legal proceedings can influence investor sentiment, the company disclosures themselves do not establish that these announcements were the direct causes of the respective share-price movements.
Note- All data presented is based on information available at the time of writing.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.Disclosure: The information mentioned above has been sourced from the company reports and a third-party database, i.e. Koyfin. Investors are advised to use strict stop-loss to protect their investments in case of any unfavorable/uncertain market events.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au